Study at a glance
How can vitamin D activity cause too much calcium in the blood?
This evidence review explains how excessive vitamin D activity can cause hypercalcaemia, meaning too much calcium in the blood. Vitamin D normally helps the intestine absorb calcium. Excessive activity can increase the calcium supply beyond what the body can control. This is different from simply having a high vitamin D blood-test result.
What can cause excessive vitamin D activity?
One cause is a very large intake of vitamin D2 or D3. Other causes include taking active vitamin D medicines, producing too much active vitamin D in certain diseases, or being unable to break vitamin D down normally. Rare faults affecting an enzyme called CYP24A1 can impair this breakdown. These are different causes, even though each can disturb calcium balance.
How can excess calcium affect the kidneys?
The kidneys can remove extra calcium through urine, sometimes before calcium becomes persistently high in blood. Too much calcium in urine can contribute to kidney stones or calcium deposits in kidney tissue. Severe high blood calcium can also contribute to dehydration and reduced kidney function. The final effect depends on both excess calcium entering the body and its removal.
Can one vitamin D result identify every cause of high calcium?
Different causes produce different blood-test patterns. Excessive active vitamin D can occur without the extremely high routine vitamin D result associated with a large D2 or D3 overdose. No single vitamin D level guarantees toxicity in everyone. Calcium measurements, other hormones, kidney function and the cause of the excess are also relevant. The review does not treat these distinct disorders as interchangeable.
Read the full article below ↓Vitamin D-induced hypercalcaemia is best understood as excessive vitamin D-mediated calcium activity rather than simply as a high vitamin D blood-test result. Different mechanisms can converge on the same endpoint. Very large vitamin D exposure can overwhelm normal handling of vitamin D metabolites; dysregulated extrarenal activation can generate excessive 1,25-dihydroxyvitamin D [1,25(OH)₂D] in granulomatous disease or some lymphomas; and impaired CYP24A1-dependent degradation can allow active vitamin D metabolites to persist abnormally. Each route can increase calcium absorption and disturb the feedback systems that normally stabilise extracellular calcium. For a shorter explanation of this evidence, see Vitamin D-Induced Hypercalcaemia: Mechanisms of Calcium Dysregulation: Study Summary.
Hypercalcaemia is the physiological toxicity problem
Vitamin D has a central role in mineral homeostasis because its active hormonal metabolite promotes intestinal calcium absorption and participates in renal, parathyroid and skeletal regulation. That normal function explains why excessive vitamin D activity can become dangerous. The problem is not that vitamin D suddenly acquires a novel toxic action. The normal calcium-regulating pathway is being driven beyond the range in which feedback and excretion can maintain stable extracellular calcium.
This relationship belongs within Vitamin D and Calcium Physiology. Calcium concentration is normally constrained by coordinated intestinal absorption, renal handling, skeletal exchange and hormones including parathyroid hormone (PTH). When vitamin D-mediated calcium entry becomes excessive, PTH falls as an appropriate counter-regulatory response. Hypercalciuria can appear before or alongside sustained hypercalcaemia as the kidneys attempt to remove the additional calcium load.
Excess vitamin D intake and excessive active-hormone activity are related but not identical
Tebben, Singh and Kumar distinguish several forms of vitamin D-mediated hypercalcaemia. In classical exogenous vitamin D intoxication, very large intake of vitamin D₂ or vitamin D₃ produces extremely high circulating 25(OH)D. At these concentrations, the normal separation between a relatively inactive circulating precursor and high-affinity active hormone becomes less secure. Supraphysiological 25(OH)D itself can contribute to VDR activation, while changes in the distribution of vitamin D metabolites and binding-protein occupancy increase biologically available ligand.
This differs from administration of calcitriol or another active vitamin D analogue. In that situation the biological system is exposed directly to a potent receptor ligand, so hypercalcaemia can occur without the extremely high 25(OH)D characteristic of ordinary vitamin D₂ or vitamin D₃ overdose. The distinction is clinically important because the metabolite pattern depends on what was actually taken.
Why intestinal calcium absorption rises
Vitamin D receptor signalling in intestinal epithelial cells regulates proteins involved in calcium transport. When active vitamin D signalling increases, the intestine can absorb a greater proportion of dietary calcium. This places a larger calcium load into the extracellular compartment. Renal calcium excretion can compensate to a point, but urinary calcium itself becomes clinically relevant because persistent hypercalciuria increases the risk of nephrolithiasis and nephrocalcinosis.
The kidney therefore has two roles in the toxicity phenotype. It is part of the normal endocrine system that regulates circulating calcitriol, and it is also one of the principal organs exposed to the consequences of calcium excess. The wider renal relationship is developed in Vitamin D and Kidneys.
Normal feedback normally restrains active vitamin D production
In normal renal physiology, CYP27B1 converts 25(OH)D into 1,25(OH)₂D while CYP24A1 begins the major catabolic pathways that reduce exposure to 25(OH)D and 1,25(OH)₂D. PTH, calcium, phosphate, FGF23 and calcitriol itself influence this balance. Rising calcium and calcitriol normally reduce the need for further active-hormone production, while calcitriol and FGF23 favour catabolic restraint.
This activation-versus-clearance balance is central to Vitamin D Clearance and Degradation. It also explains why vitamin D-mediated hypercalcaemia cannot be reduced to supplementation alone. Excess input is one route to excessive signalling, but abnormal production or abnormal degradation can reach a similar physiological endpoint from a different starting point.
CYP24A1 loss demonstrates what happens when the metabolic off-switch fails
CYP24A1 metabolises both 25(OH)D and 1,25(OH)₂D through oxidative pathways that limit the duration and magnitude of vitamin D activity. Pathogenic loss-of-function variants therefore impair disposal rather than increasing intake. This can produce hypercalcaemia, hypercalciuria, suppressed PTH, nephrolithiasis and nephrocalcinosis, with 1,25(OH)₂D sometimes high or inappropriately normal for a patient whose calcium is already elevated and PTH suppressed.
This mechanism is developed in the existing Cellular Degradation and Feedback Regulation of Vitamin D: Full Evidence Review. The distinction matters because describing CYP24A1 deficiency simply as “vitamin D overdose” would misidentify the cause. Exposure can be ordinary while metabolic clearance is abnormal.
Human disease is supported by experimental physiology. Tissue-specific Cyp24a1 deletion in mice shows that location matters: renal loss can reproduce much of the systemic phenotype of global loss, while intestinal loss can increase local vitamin D signalling and calcium handling without producing the same circulating metabolite pattern. The causal tissue evidence is examined in Renal and Intestinal CYP24A1 Regulation: Full Evidence Review.
Granulomatous disease creates a production problem rather than an intake problem
Macrophages can express CYP27B1 and convert 25(OH)D to 1,25(OH)₂D. In normal local immune physiology, that intracrine pathway is not equivalent to the tightly regulated renal endocrine system. In granulomatous disorders such as sarcoidosis and tuberculosis, activated macrophage populations can produce enough 1,25(OH)₂D for local production to become systemically important.
The resulting hypercalcaemia is therefore mechanistically different from classic exogenous hypervitaminosis D. The available 25(OH)D substrate is being converted excessively into active hormone outside normal renal control. Some lymphomas can create a related calcitriol-mediated phenotype. These pathways are already represented mechanistically in Altered CYP27B1/CYP24A1 Enzyme Activity: Full Evidence Review.
Different mechanisms produce different laboratory patterns
Mechanistic separation is useful because “vitamin D-mediated hypercalcaemia” does not imply one universal blood pattern. Exogenous vitamin D₂ or vitamin D₃ intoxication typically produces a very high 25(OH)D concentration, while circulating 1,25(OH)₂D may remain normal because renal production is suppressed. By contrast, granulomatous disease and calcitriol-producing lymphoma can produce elevated or inappropriately high 1,25(OH)₂D without the extreme 25(OH)D concentration expected in massive vitamin D overdose.
CYP24A1 deficiency adds another pattern: impaired formation of 24,25-dihydroxyvitamin D relative to 25(OH)D can reveal failure of 24-hydroxylation, while persistent active-hormone exposure is physiologically inappropriate for the accompanying hypercalcaemia and suppressed PTH. This is why metabolite relationships and PTH can carry information that a single 25(OH)D concentration cannot.
The kidney initially compensates for the calcium load
Hypercalcaemia does not necessarily appear the instant vitamin D-mediated calcium absorption increases. PTH suppression reduces PTH-dependent calcium conservation and active-hormone stimulation. The kidney can increase urinary calcium loss, providing a compensatory outlet. This helps explain why hypercalciuria can be an early or prominent feature of disorders involving excessive vitamin D activity.
Compensation has costs and limits. Persistent calcium loss into urine can promote stones or nephrocalcinosis, while severe hypercalcaemia can impair renal concentrating ability and contribute to dehydration. Reduced renal function can then make calcium homeostasis harder to stabilise. The toxicity phenotype is therefore a feedback problem involving both excessive calcium entry and the capacity of the kidney to dispose of that load.
High 25(OH)D is a risk signal, not a universal toxicity switch
The literature does not support one serum 25(OH)D concentration at which toxicity is guaranteed in every person. Reviews of vitamin D-mediated hypercalcaemia report considerable biological variability. Some individuals can have very high 25(OH)D without hypercalcaemia, while symptomatic toxicity usually occurs at substantially higher concentrations and in conjunction with disturbed calcium handling.
This is why Vitamin D Thresholds vs Targets is relevant at the high end as well as the low end. A numerical threshold can identify increasing concern or trigger investigation, but physiology does not transform discontinuously at one universal number. Serum calcium, urinary calcium, PTH, exposure history, renal function, metabolite pattern and clinical context determine whether a high vitamin D result represents biochemical excess, active toxicity or another mechanism altogether.
A tissue-specific clearance model strengthens the mechanism
The broader clearance evidence shows that CYP24A1 function is not simply a generic whole-body disposal process. Renal CYP24A1 has major systemic consequences, while intestinal CYP24A1 can modify local VDR activity and calcium absorption. The integrated evidence is synthesised in How Vitamin D Clearance Is Physiologically Regulated: Renal Feedback and Tissue-Specific Control: Evidence Synthesis.
That evidence helps explain why calcium dysregulation depends on where excessive vitamin D activity occurs. A change confined largely to one tissue may be partly buffered by renal excretion or endocrine feedback. A systemic increase in active-hormone exposure, excessive substrate, or loss of major renal catabolic capacity can overwhelm those buffers and produce sustained hypercalcaemia.
What the evidence does not establish
The evidence does not show that every high 25(OH)D concentration is toxic, that every case of hypercalcaemia in a person taking vitamin D was caused by the supplement, or that every granulomatous disorder produces calcitriol excess. It also does not justify treating CYP24A1 disease, granulomatous hypercalcaemia and excessive oral vitamin D exposure as interchangeable forms of one disorder.
The strongest interpretation is mechanistic. Vitamin D-mediated hypercalcaemia represents excessive calcium-regulating activity arising from excessive substrate exposure, excessive active-hormone production, impaired metabolite degradation or direct active-vitamin-D exposure. The final phenotype depends on how strongly that activity increases calcium entry relative to the ability of PTH suppression, renal calcium excretion and vitamin D catabolism to restore balance.
Primary scientific sources and publication details
Tebben PJ, Singh RJ, Kumar R. Vitamin D-Mediated Hypercalcemia: Mechanisms, Diagnosis, and Treatment. Endocrine Reviews. 2016;37(5):521-547. PMID: 27588937. PMCID: PMC5045493. DOI: 10.1210/er.2016-1070.
Jones G, Prosser DE, Kaufmann M. Cytochrome P450-mediated metabolism of vitamin D. Journal of Lipid Research. 2014;55(1):13-31. PMID: 23564710. PMCID: PMC3927478. DOI: 10.1194/jlr.R031534.
Schlingmann KP. Vitamin D-dependent Hypercalcemia. Endocrinology and Metabolism Clinics of North America. 2021;50(4):729-742. PMID: 34774244. DOI: 10.1016/j.ecl.2021.08.005.
Young K, Beggs MR, Grimbly C, Alexander RT. Regulation of 1 and 24 hydroxylation of vitamin D metabolites in the proximal tubule. Experimental Biology and Medicine. 2022;247(13):1103-1111. PMID: 35482362. PMCID: PMC9335508. DOI: 10.1177/15353702221091982.
Fuchs MAA, Grabner A, Shi M, et al. Intestinal Cyp24a1 regulates vitamin D locally independent of systemic regulation by renal Cyp24a1 in mice. Journal of Clinical Investigation. 2025;135(4):e179882. PMID: 39688907. PMCID: PMC11827884. DOI: 10.1172/JCI179882.
Related reading
A high calcium diet containing nonfat dry milk reduces weight gain and associated adipose tissue inflammation in diet-induced obese mice when compared to high calcium alone
Mice fed high-Ca + NFDM had reduced body weight and adiposity compared to high-Ca mice (P < 0.001).
Original paper ↗Read more →Calcium and vitamin D substitution for hypoparathyroidism after thyroidectomy: how is it continued after discharge from hospital?
Postoperative hypoparathyroidism (HypoPT) is one of the most feared complications after thyroid surgery.
Original paper ↗Read more →Cross Talk between the Calcium-Sensing Receptor and the Vitamin D System in Prevention of Cancer
Our aim was to review some of the mechanisms that drive the cross-talk between the vitamin D system and the CaSR with a special focus on the interaction in CRC cells.
Original paper ↗Read more →Effect of dietary Ca:P ratio on ionized calcium and calcium homeostasis in cats with early-stage chronic kidney disease
The aim of the study was to compare two renal foods with different Ca:P ratios on manifestation of hypercalcemia and regulation of calcium homeostasis in cats with chronic kidney disease (CKD).
Original paper ↗Read more →Efficacy and safety of prophylactic intravenous calcium supplementation in patients with secondary hyperparathyroidism after parathyroidectomy: a retrospective study
This study aimed to analyze the efficacy and safety of prophylactic intravenous calcium supplementation after PTX.
Original paper ↗Read more →Evaluation of the efficiency of calcium and vitamin D in treating adults with corticosteroid-induced osteoporosis
Electronic databases will be searched systematically to source studies that have evaluated the efficiency of calcium and vitamin D as a treatment method for adult patients with osteoporosis from corticosteroid therapy.
Original paper ↗Read more →Hypercalcemia Associated with Calcium Supplement Use: Prevalence and Characteristics in Hospitalized Patients
Objectives: To evaluate the prevalence and characteristics of hypercalcemia induced by calcium intake (“calcium supplement syndrome”; or CSS) in hospitalized patients.
Original paper ↗Read more →Implementation of Calcium and Vitamin D Supplementation in Glucocorticosteroid-Induced Osteoporosis Prevention Guidelines: Insights from Rheumatologists
Glucocorticosteroid-induced osteoporosis (GIO) is the most common cause of secondary osteoporosis but is underdiagnosed and undertreated.
Original paper ↗Read more →Steroid responsive idiopathic calcitriol induced hypercalcemia: a case report and review of the literature
Idiopathic Calcitriol Induced Hypercalcemia is a rare cause of a common condition of hypercalcemia.
Original paper ↗Read more →Vitamin D, calcium homeostasis and aging
Osteoporosis is characterized by low bone mass and microarchitecture deterioration of bone tissue, leading to enhanced bone fragility and consequent increase in fracture risk.
Original paper ↗Read more →Intestinal Cyp24a1 regulates vitamin D locally independent of systemic regulation by renal Cyp24a1 in mice
Vitamin D regulates mineral homeostasis.
Original paper ↗Read more →Vitamin D-Induced Hypercalcaemia: Mechanisms of Calcium Dysregulation: Study Summary
A concise evidence summary of how vitamin D excess, excessive calcitriol production and impaired degradation can cause hypercalcaemia.
Read more →Deregulated Renal Calcium and Phosphate Transport during Experimental Kidney Failure
Impaired mineral homeostasis and inflammation are hallmarks of chronic kidney disease (CKD), yet the underlying mechanisms of electrolyte regulation during CKD are still unclear.
Original paper ↗Read more →Loss of 24-hydroxylated catabolism increases calcitriol and fibroblast growth factor 23 and alters calcium and phosphate metabolism in fetal mice
The null fetuses were hypercalcemic, modestly hypophosphatemic (compared to Cyp24a1+/− fetuses only), with 3.5-fold increased calcitriol, 4-fold increased fibroblast growth factor 23 (FGF23), and unchanged parathyroid hormone.
Original paper ↗Read more →Status of vitamin D and parameters of calcium homeostasis in renal transplant recipients in Nepal: a cross sectional study
This study aimed to determine the prevalence of hypovitaminosis D in Nepalese RTRs and interrelations between serum 25-hydroxyvitamin D [25(OH) D] and other biochemical parameters.
Original paper ↗Read more →The dietary management of calcium and phosphate in children with CKD stages 2-5 and on dialysis: clinical practice recommendation from the Pediatric Renal Nutrition Taskforce
Complications of mineral bone disease (MBD) are common and contribute to the high morbidity and mortality seen in children with CKD.
Original paper ↗Read more →Effect of Paricalcitol vs Calcitriol on Hemoglobin Levels in Chronic Kidney Disease Patients: A Randomized Trial
Therefore, we conducted a study to determine whether paricalcitol, compared to calcitriol, improves anemia in patients with chronic kidney disease (CKD).
Original paper ↗Read more →Modulation of renal inflammation and tubular injury by calcitriol in patients with early diabetic kidney disease: a randomized controlled trial
This double-blind, randomized controlled trial investigated the effects of calcitriol supplementation on kidney injury biomarkers in patients with early DKD.
Original paper ↗Read more →Vitamin D Toxicity and Hypercalcaemia: Mechanisms, Risk and Clinical Interpretation: Evidence Synthesis
Evidence synthesis integrating vitamin D toxicity mechanisms, excessive calcitriol production, impaired clearance, hypercalcaemia risk and clinical interpretation.
Read more →Vitamin D and Calcium Physiology
Learn how vitamin D helps regulate calcium physiology, including absorption, bone mineralisation, kidney reabsorption, and hormone-driven feedback control.
Read more →Vitamin D Toxicity and Hypercalcaemia: Clinical Interpretation
Clinical context for interpreting vitamin D toxicity and hypercalcaemia, including excess calcitriol production, impaired degradation and calcium dysregulation.
Read more →Original sources
Vitamin D-Mediated Hypercalcemia: Mechanisms, Diagnosis, and Treatment
Published in Endocrine Reviews (2016).
Publication details
Tebben PJ, Singh RJ, Kumar R. Vitamin D-Mediated Hypercalcemia: Mechanisms, Diagnosis, and Treatment. Endocrine Reviews. 2016;37(5):521-547. PMID: 27588937. PMCID: PMC5045493. DOI: 10.1210/er.2016-1070.
Cytochrome P450-mediated metabolism of vitamin D
Published in Journal of Lipid Research (2014).
Publication details
Jones G, Prosser DE, Kaufmann M. Cytochrome P450-mediated metabolism of vitamin D. Journal of Lipid Research. 2014;55(1):13-31. PMID: 23564710. PMCID: PMC3927478. DOI: 10.1194/jlr.R031534.
Vitamin D-dependent Hypercalcemia
Published in Endocrinology and Metabolism Clinics of North America (2021).
Publication details
Schlingmann KP. Vitamin D-dependent Hypercalcemia. Endocrinology and Metabolism Clinics of North America. 2021;50(4):729-742. PMID: 34774244. DOI: 10.1016/j.ecl.2021.08.005.
Regulation of 1 and 24 hydroxylation of vitamin D metabolites in the proximal tubule
Published in Experimental Biology and Medicine (2022).
Publication details
Young K, Beggs MR, Grimbly C, Alexander RT. Regulation of 1 and 24 hydroxylation of vitamin D metabolites in the proximal tubule. Experimental Biology and Medicine. 2022;247(13):1103-1111. PMID: 35482362. PMCID: PMC9335508. DOI: 10.1177/15353702221091982.
Intestinal Cyp24a1 regulates vitamin D locally independent of systemic regulation by renal Cyp24a1 in mice
Vitamin D regulates mineral homeostasis.
Publication details
Fuchs MAA, Grabner A, Shi M, et al. Intestinal Cyp24a1 regulates vitamin D locally independent of systemic regulation by renal Cyp24a1 in mice. Journal of Clinical Investigation. 2025;135(4):e179882. PMID: 39688907. PMCID: PMC11827884. DOI: 10.1172/JCI179882.